Business
Revelation Biosciences Inc. Appoints Joseph A. Bellanti, M.D. to Scientific Advisory Board
- Dr. Bellanti is Director of the International Center for Interdisciplinary Studies of Immunology and Professor of Pediatrics and Microbiology and Immunology
About this update from Revelation Biosciences, Inc.
[{"type":"text","content":"- Dr. Bellanti is Director of the International Center for Interdisciplinary Studies of Immunology and Professor of Pediatrics and Microbiology and Immunology at Georgetown University SAN DIEGO, Dec. 06, 2021 (GLOBE NEWSWIRE) -- Revelation Biosciences Inc. (Revelation), a clinical-stage life sciences company that is focused on the development of immunologic‑based therapies for the prevention and treatment of disease, today announced it has appointed Joseph A. Bellanti, M.D. to its scientific advisory board. Dr. Bellanti is a Professor of Pediatrics and Microbiology and Immunology and Director of the International Center for Interdisciplinary Studies of Immunology (ICISI) at Georgetown University Medical Center. Dr. Bellanti’s investigative efforts have focused on antimicrobial research, evaluation of new vaccine strategies and developmental immunology. This work resulted in a succession of seminal research contributions including the characterization of the IgM response of the newborn, the identification of the antiviral role of secretory IgA in respiratory secretions and the cellular immune responses to viral infections following immunization or natural infection. Dr. Bellanti is the recipient of numerous awards and honors, including the prestigious E. Mead Johnson Award for Research in Pediatrics for outstanding scientific contributions, the Humanitarian Award from the American College of Allergists for “excellence and service and teaching of clinical immunology”, the Distinguished Medical Alumnus Award from the State University of Buffalo, New York and the Founder’s Day Award of Georgetown University School of Medicine. He is also the recipient of Honoris Causa degrees from the University of Palermo, Italy, Georgetown University and recently, the CEA Universidad San Pablo, Madrid, Spain. “Over the past several decades, my work has centered around generating new knowledge in immunology and translating it to clinical use,” said Dr. Bellanti. “We have seen so many advancements and innovations in this area, but still have a long way to go. The work Revelation Biosciences is doing could change the way we look at, prevent and treat stubborn and recurring infections, like influenza and COVID-19. I look forward to working with the team to develop new prevention and treatment options for the infections that impact so many people aroun...